Universal Ibogaine (TSXV:IBO) Net Change in Cash : C$0.18 Mil (TTM As of Jan. 2024)

View and export this data going back to 2017. Start your Free Trial

What is Universal Ibogaine Net Change in Cash?

Net Change in Cash is calculated as the total of Cash Flow from Operations , Cash Flow from Investing, Cash Flow from Financing, and Effect of Exchange Rate Changes.

Universal Ibogaine's Net Change in Cash for the three months ended in Jan. 2024 was C$0.21 Mil. Its Net Change in Cash for the trailing twelve months (TTM) ended in Jan. 2024 was C$0.18 Mil.

Universal Ibogaine Net Change in Cash Historical Data

The historical data trend for Universal Ibogaine's Net Change in Cash can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Universal Ibogaine Net Change in Cash Chart

Universal Ibogaine Annual Data

Trend

Mar17

Mar18

Mar19

Mar20

Mar21

Jul22

Jul23

Net Change in Cash

Get a 7-Day Free Trial

0.15

-0.13

2.10

0.58

-0.41

Universal Ibogaine Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Oct21	Jan22	Apr22	Jul22	Oct22	Jan23	Apr23	Jul23	Oct23	Jan24
Net Change in Cash	Get a 7-Day Free Trial															-0.51	0.16	-0.04	-0.15	0.21

Universal Ibogaine Net Change in Cash Calculation

Universal Ibogaine's Net Change in Cash for the fiscal year that ended in Jul. 2023 is calculated as

Net Change in Cash	=	Cash Flow from Operations	+	Cash Flow from Investing	+	Cash Flow from Financing	+	Effect of Exchange Rate Changes
	=	-1.097	+	-0.36	+	1.045	+	0
	=	-0.41

Universal Ibogaine's Net Change in Cash for the quarter that ended in Jan. 2024

Net Change in Cash = Cash Flow from Operations + Cash Flow from Investing + Cash Flow from Financing + Effect of Exchange Rate Changes

= -0.068 + -0.009 + 0.282 + 0

= 0.21

Net Change in Cash for the trailing twelve months (TTM) ended in Jan. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was C$0.18 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Universal Ibogaine Net Change in Cash Related Terms
Thank you for viewing the detailed overview of Universal Ibogaine's Net Change in Cash provided by GuruFocus.com. Please click on the following links to see related term pages.

Universal Ibogaine (TSXV:IBO) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Universal Ibogaine Inc (TSXV:IBO) » Definitions » Net Change in Cash

Comparable Companies

XCNQ:NIRV TSXV:WAVE TSXV:SVS TSXV:VXL TSXV:PSYB XCNQ:CURE XCNQ:CMND TSX:IPCI XCNQ:AGN TSXV:MRVL OCSE:NOVO B VRTX REGN ASX:CSL SGEN XKRX:207940 MRNA HKSE:02269 XBRU:ARGX BNTX

Traded in Other Exchanges

IBOGF:USA JC4:Germany

Address

400 3rd Avenue South west, Suite 1470, Calgary, AB, CAN, T2P 4H2

Website

https://www.universalibogaine.com

Universal Ibogaine Inc develops a platform of addiction treatment clinics, which use ibogaine as a primary modality for the interruption and ideally cessation of addictions to primarily opioids such as oxycodone, heroin, fentanyl, as well as alcohol, cocaine, and other stimulants. It runs addiction clinics it has a research partner clinic in Mexico.

Executives

Ian Rabb Senior Officer

Universal Ibogaine (TSXV:IBO) Headlines

No Headlines